N/A
N=77,145
Effectiveness and Implementation of mPATH-CRC
Colorectal Cancer · Cancer · Rectum Cancer · Colon Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03843957 ↗Enrolled (actual)
77,145
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Percent of Patients Who Complete the mPATH-CRC Program — 5; 4 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- mPATH-CRC (Other); mPATH-Checkin (Other); "high touch" Implementation strategy (Other); "low touch" Implementation Strategy (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Aug 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent of Patients Who Complete the mPATH-CRC Program |
5; 4 | — |
| SECONDARY mPATH-CRC Reach (by Socioeconomic Strata) |
— | — |
| SECONDARY mPATH-CRC Adoption |
— | — |
| SECONDARY mPATH-CheckIn Reach |
— | — |
| SECONDARY mPATH-CheckIn Adoption |
— | — |
| SECONDARY mPATH-CRC Implementation Fidelity |
— | — |
| SECONDARY mPATH-CRC Maintenance |
— | — |
| SECONDARY mPATH-CheckIn Maintenance |
— | — |
| SECONDARY CRC Screening Tests Ordered |
— | — |
| SECONDARY mPATH-CRC Effectiveness |
— | — |
| SECONDARY Facilitators and Barriers to Maintenance (Sustained Use of mPATH-CRC Over Time) |
— | — |
| SECONDARY mPATH-CRC Reach (by Month) |
— | — |
| SECONDARY mPATH-CRC Acceptability |
— | — |
| SECONDARY mPATH-CRC Appropriateness |
— | — |
| SECONDARY mPATH-CRC Feasibility |
— | — |
| SECONDARY mPATH-CheckIn Acceptability |
— | — |
| SECONDARY mPATH-CheckIn Appropriateness |
— | — |
| SECONDARY mPATH-CheckIn Feasibility |
— | — |
Summary
Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.
Eligibility Criteria
This study will include three distinct populations of participants: 1) healthcare providers and staff at primary care practices, 2) patients aged 18 and older seen in the participating study sites, and 3) patients aged 50-74 seen in the participating study sites who are eligible for CRC screening
Patient Inclusion Criteria:
Due for routine CRC screening, defined as:
- No colonoscopy within the prior 10 years
- No flexible sigmoidoscopy within the prior 5 years
- No CT colonography within the prior 5 years
- No fecal DNA testing within the prior 3 years
- No fecal blood testing (guaiac-based test with home kit or fecal immunochemical test) within the prior 12 months
Patient Exclusion Criteria:
- Personal history of CRC
- First degree relative with CRC
- Personal history of colorectal polyps
Data sourced from ClinicalTrials.gov (NCT03843957). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.